Get the Stockscreener App
5.03
1.41%
0.07
After Hours:
5.03
Organogenesis Holdings Inc stock is traded at $5.03, with a volume of 1.27M.
It is up +1.41% in the last 24 hours and up +9.35% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$4.96
Open:
$4.97
24h Volume:
1.27M
Relative Volume:
1.49
Market Cap:
$638.09M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
140.90
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
-1.76%
1M Performance:
+9.35%
6M Performance:
-0.20%
1Y Performance:
+86.30%
1-Day Range:
$4.9312
$5.135
1-Week Range:
$4.895
$5.195
52-Week Range:
$2.455
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
5.03 | 621.60M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Backtesting results for Organogenesis Holdings Inc. trading strategiesIndex Update & Low Risk High Reward Ideas - Newser
Organogenesis Holdings Inc. stock outlook for YEARQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
Using R and stats models for Organogenesis Holdings Inc. forecasting2025 Price Momentum & Breakout Confirmation Alerts - Newser
Is Organogenesis Holdings Inc. forming a bottoming baseJuly 2025 Gainers & Weekly Sector Rotation Insights - Newser
Is Organogenesis Holdings Inc. stock poised for growthJuly 2025 Decliners & Weekly Top Gainers Alerts - Newser
How to integrate Organogenesis Holdings Inc. into portfolio analysis toolsJuly 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Risk adjusted return profile for Organogenesis Holdings Inc. analyzedGDP Growth & Verified High Yield Trade Plans - Newser
News impact scoring models applied to Organogenesis Holdings Inc.Weekly Trading Summary & High Accuracy Trade Alerts - Newser
How did ORGO's revenue and expenses shift in Q4 2024? - AInvest
Can momentum traders help lift Organogenesis Holdings Inc.Take Profit & Reliable Price Action Trade Plans - Newser
Technical analysis overview for Organogenesis Holdings Inc. stockExit Point & Daily Stock Trend Reports - Newser
Can swing trading help recover from Organogenesis Holdings Inc. lossesInsider Buying & Daily Stock Trend Watchlist - Newser
Is Organogenesis Holdings Inc. still worth holding after the dipWeekly Trade Summary & AI Enhanced Trade Execution Alerts - Newser
Will Organogenesis Holdings Inc. see short term momentumJuly 2025 Retail & Capital Efficiency Focused Ideas - Newser
Relative strength of Organogenesis Holdings Inc. in sector analysisPrice Action & Low Drawdown Momentum Ideas - Newser
Is Organogenesis Holdings Inc. reversing from oversold territoryLong Setup & Accurate Buy Signal Alerts - Newser
What technical models suggest about Organogenesis Holdings Inc.’s comeback2025 Market Outlook & Verified Swing Trading Watchlist - Newser
Visual trend scoring systems applied to Organogenesis Holdings Inc.Quarterly Growth Report & Stepwise Trade Signal Guides - Newser
Using data filters to optimize entry into Organogenesis Holdings Inc.Market Volume Report & Weekly Chart Analysis and Trade Guides - Newser
Can Organogenesis Holdings Inc. keep up with sector leadersPortfolio Performance Report & Fast Momentum Entry Tips - khodrobank.com
Can Organogenesis Holdings Inc. deliver consistent dividendsJuly 2025 Technicals & Trade Opportunity Analysis Reports - khodrobank.com
Published on: 2025-09-01 03:01:18 - Newser
What candlestick patterns are forming on Organogenesis Holdings Inc.July 2025 Outlook & AI Based Buy/Sell Signal Reports - Newser
News impact scoring models applied to Organogenesis Holdings Inc2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
Organogenesis: Transformational Changes Taking Shape (NASDAQ:ORGO) - Seeking Alpha
Reversal indicators forming on Organogenesis Holdings Inc. stockWeekly Earnings Recap & Safe Entry Momentum Tips - Newser
Will Organogenesis Holdings Inc. rebound enough to break evenWeekly Trading Summary & Fast Gaining Stock Reports - Newser
How Organogenesis Holdings Inc. stock performs during market volatility2025 Historical Comparison & AI Driven Stock Movement Reports - Newser
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Organogenesis Holdings Inc Stock (ORGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 05 '25 |
Buy |
2.91 |
142,379 |
413,625 |
837,437 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
3.60%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):